{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:54:23Z","timestamp":1789757663175,"version":"4.0.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein 7 predict the development of acute kidney injury following renal insults of varied aetiology. To aid clinical interpretation, we describe the kinetics of biomarker elevations around an exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>In an ancillary analysis of the multicenter SAPPHIRE study, we examined the kinetics of the urinary [tissue inhibitor of metalloproteinase-2]\u2022[insulin-like growth factor binding protein 7] in association with exposure to common renal insults (major surgery, IV radiocontrast, vancomycin, nonsteroidal anti-inflammatory drugs, and piperacillin\/tazobactam).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Thirty-five sites in North America and Europe between September 2010 and June 2012.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>Seven hundred twenty-three critically ill adult patients admitted to the ICU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>\n                      We compared the urinary [tissue metalloproteinase-2]\u2022[insulin growth factor binding protein 7] kinetics from the day prior to exposure up to 5 days after exposure in patients developing acute kidney injury stage 2\u20133, stage 1, or no acute kidney injury by Kidney Disease Improving Global Outcome criteria. Among the 723 patients, 679 (94%) had at least one, 70% had more than one, and 35% had three or more exposures to a known renal insult. There was a significant association between cumulative number of exposures up to study day 3 and risk of acute kidney injury (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.02) but no association between the specific type of exposure and acute kidney injury (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.22). With the exception of radiocontrast, patients who developed acute kidney injury stage 2\u20133 after one of the five exposures, had a clear rise and fall of urinary [tissue inhibitor of metalloproteinase-2]\u2022[insulin-like growth factor binding protein 7] from the day of exposure to 24\u201348 hours later. In patients without acute kidney injury, there was no significant elevation in urinary [tissue inhibitor of metalloproteinase-2]\u2022[insulin-like growth factor binding protein 7].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Exposure to potential renal insults is common. In patients developing acute kidney injury stage 2\u20133, the kinetics of urinary [tissue inhibitor of metalloproteinase-2]\u2022[insulin-like growth factor binding protein 7] matched the exposure except in the case of radiocontrast.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000002847","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T14:04:34Z","timestamp":1511273074000},"page":"375-383","source":"Crossref","is-referenced-by-count":69,"title":["Kinetics of Urinary Cell Cycle Arrest Markers for Acute Kidney Injury Following Exposure to Potential Renal Insults"],"prefix":"10.1097","volume":"46","author":[{"given":"Marlies","family":"Ostermann","sequence":"first","affiliation":[{"name":"Department of Critical Care, King\u2019s College London, Guy\u2019s & St Thomas\u2019 Hospital, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"McCullough","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Baylor University Medical Center, Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lui G.","family":"Forni","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, Royal Surrey County Hospital NHS Foundation Trust, and Department of Clinical & Experimental Medicine, Faculty of Health Sciences, University of Surrey, Guildford, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Bagshaw","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Joannidis","sequence":"additional","affiliation":[{"name":"Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Statistics, Walker Bioscience, Carlsbad, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kianoush","family":"Kashani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Honore","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, Universitair Ziekenhuis Brussel, VUB University, Brussels, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakhmir S.","family":"Chawla","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Veterans Affairs Medical Center, Medicine, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Kellum","sequence":"additional","affiliation":[{"name":"Center for Critical Care Nephrology, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230815","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","article-title":"Epidemiology of acute kidney injury in critically ill patients: The multinational AKI-EPI study.","volume":"41","author":"Hoste","year":"2015","journal-title":"Intensive Care Med"},{"key":"R2-20230815","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ki.2013.153","article-title":"Raising awareness of acute kidney injury: A global perspective of a silent killer.","volume":"84","author":"Lewington","year":"2013","journal-title":"Kidney Int"},{"key":"R3-20230815","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0140-6736(15)60126-X","article-title":"International Society of Nephrology\u2019s 0 by 25 initiative for acute kidney injury (zero preventable deaths by 2025): A human rights case for nephrology.","volume":"385","author":"Mehta","year":"2015","journal-title":"Lancet"},{"key":"R4-20230815","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","article-title":"Acute kidney injury.","volume":"380","author":"Bellomo","year":"2012","journal-title":"Lancet"},{"key":"R5-20230815","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/ndt\/gfu016","article-title":"The economic impact of acute kidney injury in England.","volume":"29","author":"Kerr","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R6-20230815","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00134-017-4735-y","article-title":"Erratum to: Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial.","volume":"43","author":"Meersch","year":"2017","journal-title":"Intensive Care Med"},{"key":"R7-20230815","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/cc12503","article-title":"Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.","volume":"17","author":"Kashani","year":"2013","journal-title":"Crit Care"},{"key":"R8-20230815","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1097\/CCM.0000000000001827","article-title":"Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 for risk stratification of acute kidney injury in patients with sepsis.","volume":"44","author":"Honore","year":"2016","journal-title":"Crit Care Med"},{"key":"R9-20230815","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/TA.0000000000000912","article-title":"TIMP2\u2022IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients.","volume":"80","author":"Gunnerson","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"key":"R10-20230815","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1093\/ndt\/gfu292","article-title":"Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers.","volume":"29","author":"Hoste","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R11-20230815","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1164\/rccm.201401-0077OC","article-title":"Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.","volume":"189","author":"Bihorac","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R12-20230815","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/nep.13095","article-title":"Prognostic value of cell cycle arrest biomarkers in patients at high risk for acute kidney injury: A systematic review and meta-analysis.","volume":"22","author":"Jia","year":"2017","journal-title":"Nephrology (Carlton)"},{"key":"R13-20230815","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ccc.2015.06.005","article-title":"Drug-induced acute kidney injury: A focus on risk assessment for prevention.","volume":"31","author":"Kane-Gill","year":"2015","journal-title":"Crit Care Clin"},{"key":"R14-20230815","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1523-1755.2004.00927.x","article-title":"Spectrum of acute renal failure in the intensive care unit: The PICARD experience.","volume":"66","author":"Mehta","year":"2004","journal-title":"Kidney Int"},{"key":"R15-20230815","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1258\/jrsm.2010.100113","article-title":"Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009.","volume":"103","author":"Wu","year":"2010","journal-title":"J R Soc Med"},{"key":"R16-20230815","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00134-014-3592-1","article-title":"Diagnostic yield and safety of CT scans in ICU.","volume":"41","author":"Aliaga","year":"2015","journal-title":"Intensive Care Med"},{"key":"R17-20230815","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s00134-017-4761-9","article-title":"Erratum to: Post-contrast acute kidney injury in intensive care unit patients: A propensity score-adjusted study.","volume":"43","author":"McDonald","year":"2017","journal-title":"Intensive Care Med"},{"key":"R18-20230815","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/ndt\/gft510","article-title":"A basic science view of acute kidney injury biomarkers.","volume":"29","author":"Charlton","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R19-20230815","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.kint.2016.03.031","article-title":"A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury.","volume":"90","author":"Goldstein","year":"2016","journal-title":"Kidney Int"},{"key":"R20-20230815","first-page":"1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury.","volume":"2","year":"2012","journal-title":"Kidney Int"},{"key":"R24-20230815","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0272-6386(12)81128-0","article-title":"Community-acquired acute renal failure.","volume":"17","author":"Kaufman","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"R25-20230815","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.294.7.813","article-title":"Acute renal failure in critically ill patients: A multinational, multicenter study.","volume":"294","author":"Uchino","year":"2005","journal-title":"JAMA"},{"key":"R27-20230815","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00134-017-4832-y","article-title":"Prevention of acute kidney injury and protection of renal function in the intensive care unit: Update 2017: Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.","volume":"43","author":"Joannidis","year":"2017","journal-title":"Intensive Care Med"},{"key":"R28-20230815","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2215\/CJN.02050309","article-title":"Renal vulnerability to drug toxicity.","volume":"4","author":"Perazella","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R29-20230815","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nbt0510-436","article-title":"Next-generation biomarkers for detecting kidney toxicity.","volume":"28","author":"Bonventre","year":"2010","journal-title":"Nat Biotechnol"},{"key":"R30-20230815","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ki.2013.374","article-title":"Potential use of biomarkers in acute kidney injury: Report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference.","volume":"85","author":"Murrary","year":"2014","journal-title":"Kidney Int"},{"key":"R31-20230815","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3109\/15563650.2011.615319","article-title":"Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.","volume":"49","author":"Waring","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"key":"R32-20230815","doi-asserted-by":"crossref","first-page":"F284","DOI":"10.1152\/ajprenal.00271.2016","article-title":"Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: Differential expression and secretion in human kidney tubule cells.","volume":"312","author":"Emlet","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"R33-20230815","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40635-016-0086-1","article-title":"Cross-species validation of cell cycle arrest markers for acute kidney injury in the rat during sepsis.","volume":"4","author":"Peng","year":"2016","journal-title":"Intensive Care Med Exp"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003246-201803000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T20:01:43Z","timestamp":1692129703000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003246-201803000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000002847","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}